EDGAR Filing Documents for 0001157523-07-012366

Form SB-2/A - Optional form for registration of securities to be sold to the public by small business issuers: [Amend]

SEC Accession No. 0001157523-07-012366

Filing Date

2007-12-20

Accepted

2007-12-20 15:43:53

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	OPEXA THERAPEUTICS, INC.	a5571729.htm	SB-2/A	2639736
2	EXHIBIT 1.1	a5571729ex1_1.htm	EX-1.1	202336
3	EXHIBIT 4.2	a5571729ex4_2.htm	EX-4.2	1592
4	EXHIBIT 4.3	a5571729ex4_3.htm	EX-4.3	156750
5	EXHIBIT 4.4	a5571729ex4_4.htm	EX-4.4	121334
6	EXHIBIT 4.5	a5571729ex4_5.htm	EX-4.5	124993
7	EXHIBIT 23.1	a5571729ex23_1.htm	EX-23.1	6047
8	TOVAXIN PAGE	tovaxin.jpg	GRAPHIC	125532
9	LOGO	logo.jpg	GRAPHIC	4581
10	CERTIFICATE 2	exhibit4-2pg2.jpg	GRAPHIC	85529
11	CERTIFICATE	exhibit4-2pg1.jpg	GRAPHIC	163928
12		mb.jpg	GRAPHIC	6978
	Complete submission text file	0001157523-07-012366.txt		3787746

Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381

Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331

Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)